These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36314534)

  • 21. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
    Fein KC; Gleeson JP; Newby AN; Whitehead KA
    Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals.
    Kim JC; Park EJ; Na DH
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SNAC for Enhanced Oral Bioavailability: An Updated Review.
    Kommineni N; Sainaga Jyothi VGS; Butreddy A; Raju S; Shapira T; Khan W; Angsantikul P; Domb AJ
    Pharm Res; 2023 Mar; 40(3):633-650. PubMed ID: 36539668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spermined dextran, a cationized polymer, as absorption enhancer for pulmonary application of peptide drugs.
    Morimoto K; Fukushi N; Chono S; Seki T; Tabata Y
    Pharmazie; 2008 Mar; 63(3):180-4. PubMed ID: 18444505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration.
    Granhall C; Bækdal TA; Breitschaft A; Søndergaard FL; Anderson TW; Thomsen M
    Diabetes Ther; 2021 Sep; 12(9):2599-2610. PubMed ID: 34319564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prophylactic antibiotics administration on barrier properties of intestinal mucosa and mucus from preterm born piglets.
    Mortensen JS; Nguyen DN; Mørck Nielsen H; Rønholt S
    Drug Deliv Transl Res; 2023 May; 13(5):1456-1469. PubMed ID: 36884193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of C10 and SNAC erodible tablets for gastric delivery of a GIP/GLP1 peptide in monkeys.
    Tran H; Dogra M; Huang S; Aihara E; ElSayed M; Aburub A
    Int J Pharm; 2024 Jan; 650():123680. PubMed ID: 38070657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral absorption enhancement of cromolyn sodium through noncovalent complexation.
    Ding X; Rath P; Angelo R; Stringfellow T; Flanders E; Dinh S; Gomez-Orellana I; Robinson JR
    Pharm Res; 2004 Dec; 21(12):2196-206. PubMed ID: 15648250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus.
    Wright L; Barnes TJ; Joyce P; Prestidge CA
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
    Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
    Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and intestinal mucus penetration mechanism of core-shell nanocomplex.
    Zhang X; Cheng H; Dong W; Zhang M; Liu Q; Wang X; Guan J; Wu H; Mao S
    J Control Release; 2018 Feb; 272():29-38. PubMed ID: 29305112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?
    Bohley M; Leroux JC
    Adv Sci (Weinh); 2024 Sep; 11(33):e2400843. PubMed ID: 38884149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peri- and postnatal developmental toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley rats.
    Riley MG; York RG
    Int J Toxicol; 2009; 28(4):266-77. PubMed ID: 19636070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.
    Hossain S; Kneiszl R; Larsson P
    Nanoscale; 2023 Dec; 15(47):19180-19195. PubMed ID: 37982184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats.
    Riley MG; Castelli MC; Paehler EA
    Int J Toxicol; 2009; 28(4):278-93. PubMed ID: 19636071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of the mucus barrier by topically applied exogenous particles.
    McGill SL; Smyth HD
    Mol Pharm; 2010 Dec; 7(6):2280-8. PubMed ID: 20919744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing Intestinal Absorption of a Model Macromolecule via the Paracellular Pathway using E-Cadherin Peptides.
    Dening TJ; Siahaan TJ; Hageman MJ
    J Pharm Sci; 2021 May; 110(5):2139-2148. PubMed ID: 33359310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration Enhancement Strategies for Intradermal Delivery of Cromolyn Sodium.
    Holman M; Tijani A; Klein J; Frempong D; Dinh S; Puri A
    AAPS PharmSciTech; 2022 Jun; 23(6):171. PubMed ID: 35739411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.